Clinical utility of circulating non-coding RNAs—an update

S Anfossi, A Babayan, K Pantel, GA Calin - Nature reviews Clinical …, 2018 - nature.com
Over the past decade, the amount of research and the number of publications on
associations between circulating small and long non-coding RNAs (ncRNAs) and cancer …

Circulating microRNAs: Biomarkers of disease

Y Wu, Q Li, R Zhang, X Dai, W Chen, D Xing - Clinica Chimica Acta, 2021 - Elsevier
MicroRNAs are a class of endogenous noncoding single-stranded RNA molecules with
approximately 20–24 nucleotides and are associated with a broad range of biological …

Emerging digital PCR technology in precision medicine

L Zhang, R Parvin, Q Fan, F Ye - Biosensors and Bioelectronics, 2022 - Elsevier
Digital PCR (dPCR) is built on partitioning reagent to the extent that single template
molecules are amplified and visualized individually, whereby offers higher precision and …

microRNA‐based diagnostic and therapeutic applications in cancer medicine

LF Sempere, AS Azmi, A Moore - Wiley Interdisciplinary …, 2021 - Wiley Online Library
It has been almost two decades since the first link between microRNAs and cancer was
established. In the ensuing years, this abundant class of short noncoding regulatory RNAs …

MicroRNAs as peripheral biomarkers in aging and age-related diseases

S Kumar, M Vijayan, JS Bhatti, PH Reddy - Progress in molecular biology …, 2017 - Elsevier
MicroRNAs (miRNAs) are found in the circulatory biofluids considering the important
molecules for biomarker study in aging and age-related diseases. Blood or blood …

MicroRNAs as biomarkers for prostate cancer prognosis: a systematic review and a systematic reanalysis of public data

S Rana, GN Valbuena, E Curry, CL Bevan… - British journal of …, 2022 - nature.com
Background Reliable prognostic biomarkers to distinguish indolent from aggressive prostate
cancer (PCa) are lacking. Many studies investigated microRNAs (miRs) as PCa prognostic …

Three-dimensional hierarchical plasmonic nano-architecture based label-free surface-enhanced Raman spectroscopy detection of urinary exosomal miRNA for …

WH Kim, JU Lee, MJ Jeon, KH Park, SJ Sim - Biosensors and Bioelectronics, 2022 - Elsevier
The urinary exosomal miRNAs are recently emerging prostate cancer (PC)-associated
biomarkers for the early-stage diagnosis and prognosis due to their non-invasiveness …

Potential miRNA use as a biomarker: from breast cancer diagnosis to metastasis

E Jordan-Alejandre, AD Campos-Parra… - Cells, 2023 - mdpi.com
Breast cancer is the most common cancer in women. Despite advances in diagnosis and
prognosis, distal metastases occur in these patients in up to 15% of cases within 3 years of …

MicroRNAs in prostate cancer: Functional role as biomarkers

R Kanwal, AR Plaga, X Liu, GC Shukla, S Gupta - Cancer Letters, 2017 - Elsevier
MicroRNAs (miRNAs) are small endogenous non-coding molecules that alters gene
expression through post-transcriptional regulation of messenger RNA. Compelling evidence …

Nanoarchitectonics-assisted simultaneous fluorescence detection of urinary dual miRNAs for noninvasive diagnosis of prostate cancer

P Jiang, Y Bai, L Yan, P Feng, K Huang… - Analytical …, 2023 - ACS Publications
Herein, we report a fluorescence strategy for the homogeneous and simultaneous analysis
of urine miRNA-375 and miRNA-148a. The target miRNAs in urine bonded the devised …